New materials to remove harmful chemicals from water
Official title: Novel sorbents for removal of PFAS from water
Funded at Sorbenta INC · NIH-10921394 · Data updated 2026-11-12
This study is working on new materials that can help clean harmful 'forever chemicals' out of our water, making it safer to drink and protecting our health.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Sorbenta INC NIH-funded |
| Lab location | 1 site (Carrboro, United States) |
| Project start | July 13, 2024 |
| Project end | June 30, 2026 |
| Funding year | 2024 |
| Award (this year) | $295,923 |
| NIH project number | 1R41ES036472-01 |
| Project ID | NIH-10921394 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals living in areas with known PFAS contamination in their water supply.
✕Less likely to help
Patients who do not reside in areas affected by PFAS contamination may not benefit from this research.
What this research studies
This research focuses on developing innovative sorbents designed to effectively remove PFAS, a group of toxic chemicals known as 'forever chemicals', from water sources. These chemicals have been linked to serious health issues, including cancer and pregnancy complications. The project aims to create more efficient and sustainable methods for water treatment that can be integrated into existing systems, addressing a significant environmental and public health concern. By improving the removal of PFAS from water, this research seeks to enhance the safety of drinking water supplies.
Why it matters
Potential benefit: If successful, this research could lead to safer drinking water by effectively eliminating harmful PFAS chemicals from water sources.
How similar studies have gone: Previous research has shown promise in developing new materials for water purification, indicating potential for success in this novel approach.
Where this research is happening
-
Sorbenta INC
Carrboro, United States Active
Researchers
- Principal investigator: Weitkamp, Robin — Sorbenta INC
- Study coordinator: Weitkamp, Robin
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.